e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Treatment of asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Safety of 5-grass pollen extract sublingual tablet in patients with grass pollen-induced allergic rhinoconjunctivitis and concomitant intermittent asthma: A pooled analysis
R. K. Zeldin, Y. Amistani, J. Cognet-Sicé, K. Abiteboul (Antony, France)
Source:
Annual Congress 2013 –Treatment of asthma
Session:
Treatment of asthma
Session type:
Thematic Poster Session
Number:
911
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. K. Zeldin, Y. Amistani, J. Cognet-Sicé, K. Abiteboul (Antony, France). Safety of 5-grass pollen extract sublingual tablet in patients with grass pollen-induced allergic rhinoconjunctivitis and concomitant intermittent asthma: A pooled analysis. Eur Respir J 2013; 42: Suppl. 57, 911
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Related content which might interest you:
Sublingual tablets of house dust mite allergen extracts: Results of a phase I study in adults with mite-associated allergic asthma
Source: Annual Congress 2013 –Studies of asthma in man
Year: 2013
Efficacy and safety of 300IR 5-grass pollen sublingual tablet in allergic patients with and without asthma
Source: Annual Congress 2012 - Clinical aspects and treatment of asthma and allergic respiratory diseases
Year: 2012
Omalizumab is equally effective in persistent allergic oral corticosteroid-dependent asthma whether due to seasonal allergens or to perennial allergens
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
High doses of sublingual tablets of house dust mite allergen extracts: Lung function assessment in a phase I study in adults with mite-associated allergic asthma
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015
Comparative efficacy of different groups of drugs for the treatment of bronchial asthma in combination with allergic rhinitis
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014
QAV680, cetirizine and their combination reduce nasal symptoms in patients with intermittent allergic rhinitis in an environmental exposure chamber
Source: International Congress 2014 – Allergy and asthma: novel findings based on human cell biology
Year: 2014
No increase in non-specific bronchial hyperreactivy in patients with cypress pollen allergy during the pollen season
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
Effects of airborne pollen levels on drug consumption for seasonal allergic rhinoconjunctivitis: A ten-year French study
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014
Efficacy of ruzam in the treatment of patients with perennial allergic rhinitis
Source: Eur Respir J 2004; 24: Suppl. 48, 131s
Year: 2004
Unexpected severe systemic allergic reaction after hymenoptera sting in well controlled asthma during treatment with omalizumab
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014
Therapeutic effectpredictors during sublingual immunotherapy for Japanese seasonal allergic rhinitis
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014
Citizen science based symptom scores of allergic rhinitis to validate the grass pollen hay fever forecast
Source: International Congress 2015 – Indoor air and ambient pollution
Year: 2015
Subcutaneous allergen specific immunotherapy and immunological response in patients with bronchial asthma and allergic rhinitis in India
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014
Skin prick test versus specific IgE – A comparative study in patients with bronchial asthma and allergic rhinitis in India
Source: International Congress 2014 – Clinical allergy
Year: 2014
Should patients with mild asthma be excluded from allergic rhinitis drug trials?
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015
Ultra-rush sublingual immunotherapy: Safety of use for patients with various allergic manifestations
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015
Combined therapy of asthma and allergic rhinitis
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
Clinical efficiency of sublingual and subcutaneous allergenspecific immunotherapy with household dust mite allergen in patients with persistent allergic rhinitis
Source: Eur Respir J 2006; 28: Suppl. 50, 438s
Year: 2006
Autoimmune disorders in allergen immunotherapy, allergic rhinitis, and non-allergic patients
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014
Collaborative treatment with variety of dust mites allergic in standardized dermatophagoides pteronyssinus allergen immunotherapy
Source: International Congress 2016 – Clinical studies in asthma and immunology
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept